Joanne Ewing

1.4k total citations
19 papers, 503 citations indexed

About

Joanne Ewing is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Joanne Ewing has authored 19 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 9 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in Joanne Ewing's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Acute Myeloid Leukemia Research (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Joanne Ewing is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Acute Myeloid Leukemia Research (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Joanne Ewing collaborates with scholars based in United Kingdom, United States and Spain. Joanne Ewing's co-authors include Adam J. Mead, Steven Knapper, Claire Harrison, Donal P. McLornan, Mary Frances McMullin, Anne Armstrong, David L. Eaton, Mamta Garg, Frances Wadelin and Frederick Chen and has published in prestigious journals such as Blood, British Journal of Haematology and Expert Review of Vaccines.

In The Last Decade

Joanne Ewing

17 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanne Ewing United Kingdom 8 260 208 127 93 91 19 503
D. Macdonald United Kingdom 12 137 0.5× 202 1.0× 138 1.1× 70 0.8× 134 1.5× 14 475
Man Updesh Singh Sachdeva India 13 185 0.7× 245 1.2× 48 0.4× 107 1.2× 126 1.4× 118 648
Emma M. Groarke United States 14 290 1.1× 323 1.6× 289 2.3× 62 0.7× 164 1.8× 57 702
Hiromi Koiso Japan 12 110 0.4× 152 0.7× 60 0.5× 94 1.0× 128 1.4× 44 426
Matthew T. Howard United States 12 174 0.7× 115 0.6× 46 0.4× 185 2.0× 79 0.9× 55 466
Murat Tombuloğlu Türkiye 11 84 0.3× 231 1.1× 44 0.3× 87 0.9× 78 0.9× 63 453
Caroline Piatek United States 11 193 0.7× 247 1.2× 66 0.5× 75 0.8× 334 3.7× 40 623
Mariko Yabe United States 14 138 0.5× 128 0.6× 53 0.4× 65 0.7× 113 1.2× 39 466
Odile Beyne Rauzy France 9 173 0.7× 450 2.2× 47 0.4× 180 1.9× 78 0.9× 31 608
J Sans-Sabrafén Spain 14 337 1.3× 264 1.3× 75 0.6× 178 1.9× 74 0.8× 51 556

Countries citing papers authored by Joanne Ewing

Since Specialization
Citations

This map shows the geographic impact of Joanne Ewing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Ewing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Ewing more than expected).

Fields of papers citing papers by Joanne Ewing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Ewing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Ewing. The network helps show where Joanne Ewing may publish in the future.

Co-authorship network of co-authors of Joanne Ewing

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne Ewing. A scholar is included among the top collaborators of Joanne Ewing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne Ewing. Joanne Ewing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Tapper, William, Joannah Score, Andrew Chase, et al.. (2025). Genome-wide analysis defines genetic determinants of MPN subtypes and identifies a sex-specific association at CDH22 / CD40. Blood. 146(26). 3228–3233.
2.
Mead, Adam J., Nauman M. Butt, Ciro R. Rinaldi, et al.. (2022). A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK study. Therapeutic Advances in Hematology. 13. 1554002247–1554002247. 4 indexed citations
3.
Ewing, Joanne, et al.. (2021). COVID‐19‐associated oxidative damage to red blood cells. British Journal of Haematology. 193(3). 481–481. 9 indexed citations
4.
Lokare, Anand, et al.. (2020). Thrombocytopenia as an initial manifestation of COVID‐19; case series and literature review. British Journal of Haematology. 189(6). 1057–1058. 30 indexed citations
5.
Mead, Adam J., Tim C. P. Somervaille, Nauman M. Butt, et al.. (2019). A Retrospective Real-World Study of the Current Treatment Pathways for Myelofibrosis in the UK (The REALISM UK Study). Blood. 134(Supplement_1). 1671–1671.
6.
7.
McMullin, Mary Frances, Claire Harrison, Catherine Cargo, et al.. (2018). A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline. British Journal of Haematology. 184(2). 176–191. 94 indexed citations
8.
McMullin, Mary Frances, Adam J. Mead, Sahra Ali, et al.. (2018). A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis. British Journal of Haematology. 184(2). 161–175. 70 indexed citations
9.
Murthy, Vidhya, et al.. (2018). Azacitidine Improves Outcome in Patients with MDS and AML with High Risk Cytogenetics - a Single Center Experience. Blood. 132(Supplement 1). 5529–5529. 2 indexed citations
10.
Butt, Nauman M., Jonathan Lambert, Sahra Ali, et al.. (2017). Guideline for the investigation and management of eosinophilia. British Journal of Haematology. 176(4). 553–572. 83 indexed citations
11.
Scherber, Robyn M., Steven Knapper, Sonia Fox, et al.. (2015). Assessment and Validation of the EQ-5D Among a Population of Myeloproliferative Neoplasm Patients. Blood. 126(23). 5179–5179. 1 indexed citations
12.
Gardie, Betty, Melanie J. Percy, David Hoogewijs, et al.. (2014). The role of PHD2 mutations in the pathogenesis of erythrocytosis. PubMed. 2. 71–71. 37 indexed citations
13.
14.
Delgado, Julio, Kirsty Thomson, Nigel H. Russell, et al.. (2005). Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study. Blood. 107(4). 1724–1730. 116 indexed citations
15.
Ewing, Joanne, Joanne White, A Rattray, A M Lessells, & M.J. Mackie. (2003). Total Registration of Non-Hodgkin's Lymphoma and Hodgkin's Disease in Scotland: Effect of Deprivation and Caseload on Outcome. Hematology. 8(4). 211–220. 5 indexed citations
16.
17.
Armstrong, Anne, David L. Eaton, & Joanne Ewing. (2002). Cellular vaccine therapy for cancer. Expert Review of Vaccines. 1(3). 303–316. 6 indexed citations
18.
Armstrong, Anne, David L. Eaton, & Joanne Ewing. (2001). Cellular immunotherapy for cancer. BMJ. 323(7324). 1289–1293. 34 indexed citations
19.
Fairbairn, Leslie J. & Joanne Ewing. (2001). Prospects for gene therapy using haemopoietic stem cells. Best Practice & Research Clinical Haematology. 14(4). 823–834. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Macdonald Breakdown of academic impact, for papers by Man Updesh Singh Sachdeva Breakdown of academic impact, for papers by Emma M. Groarke Breakdown of academic impact, for papers by Hiromi Koiso Breakdown of academic impact, for papers by Matthew T. Howard Breakdown of academic impact, for papers by Murat Tombuloğlu Breakdown of academic impact, for papers by Caroline Piatek Breakdown of academic impact, for papers by Mariko Yabe Breakdown of academic impact, for papers by Odile Beyne Rauzy Breakdown of academic impact, for papers by J Sans-Sabrafén
Rankless by CCL
2026